Suchergebnisse - "Dai, Yile"

PubPharm (29)

1

Neuroinvasion of SARS-CoV-2 in human and mouse brain

enthalten in: bioRxiv.org | 2024

von Song, E. | Zhang, C. | Israelow, B. | +36

2

Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein

enthalten in: bioRxiv.org | 2024

von Lapidus, S. | Liu, F. | Casanovas-Massana, A. | +57

3

Distinguishing features of Long COVID identified through immune profiling

enthalten in: bioRxiv.org | 2024

von Klein, J. | Wood, J. | Jaycox, J. | +32

4

A host-microbiota interactome reveals extensive transkingdom connectivity

enthalten in: Nature | 2024

von Sonnert, N. | Rosen, C. | Ghazi, A. | +18

5

Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Lin, M. | Xiao, Y. | Dai, Y. | +4

6

Improved Performance of QDSSCs Can Be Achieved by Constructing a Transparent Anatase TiO2MWCNT Photoanode Based on the Bionic Mountain Lotus

enthalten in: ACS applied materials & interfaces | 2024

von Jiang, Y. | Dai, Y. | Xie, X. | +2

7

Machine learning models and nomogram based on clinical, laboratory profiles and skeletal muscle index to predict pancreatic fistula after pancreatoduodenectomy

enthalten in: Gland surgery | 2024

von Dai, Y. | Huang, W. | Xu, L. | +2

8

Decoding the autoantibody reactome

enthalten in: Science (New York, N.Y.) | 2024

von Jaycox, J. | Dai, Y. | Ring, A.

9

Distinguishing features of long COVID identified through immune profiling

enthalten in: Nature | 2023

von Klein, J. | Wood, J. | Jaycox, J. | +44

UpdateOf: medRxiv. 2022 Aug 10;:. - PMID 35982667

10

Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway

enthalten in: Clinical and translational oncology | 2023

von Lin, M. | Xiao, Y. | Dai, Y. | +4